Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
69.35 EUR | +1.31% | -7.31% | -12.91% |
Jun. 05 | Baader Bank lowers target for Compugroup to 57 euros - 'Buy' | DP |
Jun. 05 | COMPUGROUP MEDICAL : Buy rating from Baader Bank | ZD |
Sales 2024 * | 1.24B 1.33B | Sales 2025 * | 1.29B 1.39B | Capitalization | 1.31B 1.4B |
---|---|---|---|---|---|
Net income 2024 * | 89M 95.58M | Net income 2025 * | 107M 115M | EV / Sales 2024 * | 1.59 x |
Net Debt 2024 * | 665M 714M | Net Debt 2025 * | 590M 634M | EV / Sales 2025 * | 1.47 x |
P/E ratio 2024 * |
15.2
x | P/E ratio 2025 * |
12.3
x | Employees | - |
Yield 2024 * |
3.1% | Yield 2025 * |
3.19% | Free-Float | 46.84% |
Latest transcript on CompuGroup Medical Societas Europaea
1 day | +1.31% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Rauch
CEO | Chief Executive Officer | 52 | 19-07-31 |
Frank Gotthardt
CEO | Chief Executive Officer | 72 | 86-12-31 |
Daniel Gotthardt
BRD | Director/Board Member | - | 03-08-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Gotthardt
BRD | Director/Board Member | - | 03-08-21 |
Director/Board Member | 59 | 20-06-17 | |
Klaus Esser
BRD | Director/Board Member | - | 03-05-25 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.65% | 386B | |
+27.60% | 228B | |
+0.46% | 148B | |
+15.21% | 59.69B | |
+18.47% | 34.06B | |
-2.33% | 30.14B | |
+134.93% | 28.44B | |
+31.23% | 21.48B | |
+4.74% | 13.7B |
- Stock Market
- Equities
- COP Stock
- COP Stock